000 01288 a2200373 4500
005 20250517115635.0
264 0 _c20170619
008 201706s 0 0 eng d
022 _a1530-6550
024 7 _a10.3909/ricm0854
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBaum, Seth J
245 0 0 _aEmerging Treatments for Heterozygous and Homozygous Familial Hypercholesterolemia.
_h[electronic resource]
260 _bReviews in cardiovascular medicine
_c2016
300 _a16-27 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Review
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAnticholesteremic Agents
_xtherapeutic use
650 0 4 _aBenzimidazoles
_xtherapeutic use
650 0 4 _aBlood Component Removal
650 0 4 _aFemale
650 0 4 _aGenetic Therapy
650 0 4 _aHeterozygote
650 0 4 _aHomozygote
650 0 4 _aHumans
650 0 4 _aHyperlipoproteinemia Type II
_xdiagnosis
650 0 4 _aMale
650 0 4 _aOligonucleotides
_xtherapeutic use
700 1 _aSoffer, Daniel
700 1 _aBarton Duell, P
773 0 _tReviews in cardiovascular medicine
_gvol. 17
_gno. 1-2
_gp. 16-27
856 4 0 _uhttps://doi.org/10.3909/ricm0854
_zAvailable from publisher's website
999 _c26453482
_d26453482